Posttransplantation systemic immunomodulation with SA-FasL-engineered donor splenocytes has robust efficacy in preventing cardiac allograft rejection in mice

Transplantation Proceedings

Volumn 45, Issue 5, 2013, Pages 1805-1807

  Zhao, H ^a   Woodward, K B ^a   Shirwan, H ^a   Grimany Nuno, O ^a   Yolcu, E S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; RAPAMYCIN; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; CARDIAC GRAFT REJECTION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CELL TRANSPLANTATION; FAS LIGAND PROTEIN; GRAFT REJECTION; HEART TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; STREPTAVIDIN;

EID: 84879245228     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.01.049     Document Type: Conference Paper

References (10)

1. N. Askenasy, E.S. Yolcu, I. Yaniv lnduction of tolerance using Fas ligand: a double-edged immunomodulator Blood 105 2004 1396 1404
2. K.M. Swenson, B. Ke, T. Wang Fas ligand gene transfer to renal allografts in rats: effects on allograft survival Transplantation 65 1998 155 160
3. H.T. Lau, M. Yu, A. Fontana Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice Science 273 1996 109 112
4. S.M. Kang, D. Braat, D.B. Schneider A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants Transplantation 69 2000 1813 1817
5. L. Toumeur, B. Malassagne, F. Batteux Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts J Immunol 167 2001 1338 1346
6. J. Allison, H.M. Georgiou, A. Strasser Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts Proc Natl Acad Sci USA 94 1997 3943 3947
7. T. Takeuchi, T. Ueki, H. Nishimatsu Accelerated rejection of Fas ligand-expressing heart grafts J Immunol 162 1999 518 522
8. L.A. O'Reilly, L. Tai, L. Lee Membrane-bound Fas ligand only is essential for Fas-induced apoptosis Nature 461 2009 659 663
9. E.S. Yolcu, X. Gu, C. Lacelle Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous Fas ligand protein J Immunol 181 2008 931 939
10. E.S. Yolcu, N. Askenasy, N.P. Singh Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection Immunity 17 2002 795 808